The first case report of a patient with acquired factor XIII deficiency in the context of autoimmune encephalitis

Haemophilia ◽  
2017 ◽  
Vol 23 (5) ◽  
pp. e461-e464 ◽  
Author(s):  
I. Soto ◽  
A. Bernardo ◽  
T. Arias ◽  
C. Ramón ◽  
I. Noval ◽  
...  
2020 ◽  
Vol 19 (2) ◽  
pp. 108-111
Author(s):  
Saurav Khetan ◽  
Nikhil Agrawal ◽  
Prakash Rajoli

Anti-NMDA encephalitis is second commonest cause of autoimmune encephalitis among children; however, it is hardly diagnosed and often not considered as one of the differentials when a child presents with encephalitis-related symptoms. In children, it presents mostly with seizures or psychiatric symptoms without prodrome. Here we present a six years old girl who presented with seizures and inappropriate behaviour. We investigated her in the line of viral encephalitis such as Japanese Encephalitis, which is very common in our region. However, results were not suggestive of Japanese Encephalitis and further investigations subsequently lead to diagnosis of anti- NMDA encephalitis. This is probably one of the first case report of this disease in our country. We want to highlight the significance of high index of suspicion for looking out for an organic cause in any child who presents with psychiatric symptoms, along with seizures.


2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
David B. Carroll ◽  
Conrad Myler ◽  
Natthapol Songdej ◽  
Khaled Sedeek ◽  
Dmitri Bezinover

Factor XIII (FXIII) deficiency is a rare coagulation defect that can be associated with significant bleeding. A 28-year-old pregnant woman, with a history of hemorrhagic stroke secondary to severe congenital FXIII deficiency, presented in active labor requesting an epidural. Factor XIII levels had been monitored throughout her pregnancy and treated with intermittent factor XIII infusions to maintain factor levels above 30% of normal. After careful multidisciplinary peripartum evaluation and FXIII replacement, neuraxial analgesia was performed without complication. Neuraxial analgesia can be performed without complication in patients with FXIII deficiency if FXIII levels are carefully managed and no other coagulopathy exists.


2005 ◽  
pp. 380-382
Author(s):  
E. Rusicke ◽  
V. Ivaskevicius ◽  
D. Klarmann ◽  
C. Escuriola Ettingshausen ◽  
J. Oldenburg ◽  
...  

2012 ◽  
Vol 3 (6) ◽  
pp. 174-175
Author(s):  
Dr.Shivaprakash N C Dr.Shivaprakash N C ◽  
◽  
Dr.Kedarnath G T Dr.Kedarnath G T ◽  
Dr Uday Shankar S

2020 ◽  
Vol 2020 ◽  
pp. 1-5
Author(s):  
Ryoichi Maenosono ◽  
Tomohisa Matsunaga ◽  
Hajime Hirano ◽  
Hayahito Nomi ◽  
Shunri Taniguchi ◽  
...  

Despite the evolution of transplantation techniques, urological complications are common and result in loss of graft. We report the case of a 57-year-old man who developed continuous urine leakage despite pyeloureteral neoanastomosis and stenting after kidney transplantation from his dizygotic twin. Suspecting ureteral leakage, we performed pyeloureteral neoanastomosis using his native right ureter and a ureteral stent 5 days after the kidney transplant. However, urine leakage continued for several days. Because the plasma factor XIII level decreased to 48%, we administered factor XIII products (Fibrogammin P; CSL Behring, King of Prussia, PA) after the surgery. Although its utility and safety in patients with renal failure and/or transplantation are unclear, urine leakage stopped after the infusion of fibrogammin without any side effects. This is the first case report of the use of factor XIII for refractory urine leakage after kidney transplantation. Although further studies are needed, administration of factor XIII products could be one option for refractory urine leakage after transplantation.


2021 ◽  
Vol Volume 12 ◽  
pp. 63-68
Author(s):  
Ana Marco ◽  
Pascual Marco

1989 ◽  
Vol 10 (6) ◽  
pp. 579-582
Author(s):  
C. Giraldi ◽  
S. Creta ◽  
A. Martini ◽  
C. Ioppoli ◽  
A. Valleriani ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document